Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 10Endometrial Neoplasms 6Fallopian Tube Neoplasms 4Breast Neoplasms 4Neoplasms 3Carcinoma, Ovarian Epithelial 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Paget's Disease, Mammary 1Neoplasms by Site 1Hereditary Sensory and Autonomic Neuropathies 1Hereditary Breast and Ovarian Cancer Syndrome 1Head and Neck Neoplasms 1Endometrial Hyperplasia 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1Breast Carcinoma In Situ 1Advanced, Persistent, or Recurrent Endometrial Cancer 1

Interventions

Surveys and Questionnaires 3Blood Specimen Collection 3veliparib 2Salpingo-oophorectomy 2Genetic Testing 2Genetic Counseling 2Diet, Mediterranean 2Counseling 2Carboplatin 2prexasertib 1Zoledronic Acid 1Videotape Recording 1Telemedicine 1Taxes 1Tamoxifen 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Salpingectomy 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1Palliative Care 1Paclitaxel 1Ovariectomy 1Methods 1Letrozole 1Hysterectomy 1High-Throughput Nucleotide Sequencing 1Genotype 1Exercise Test 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Breast and Ovarian Cancer Syndrome × Tamoxifen × Gynecologic × Clear all
NCT00253539 2011-04-13

Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

The Cleveland Clinic

Phase 2 Completed
3 enrolled
BreastGynecologic

Breast Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡